期刊
MOLECULAR CELL
卷 63, 期 6, 页码 1021-1033出版社
CELL PRESS
DOI: 10.1016/j.molcel.2016.08.009
关键词
-
资金
- Stony Brook School of Medicine and Cancer Center
- TRO Carol M. Baldwin Award
- Feldstein Medical Foundation
- Peter Rowley Breast Cancer Research Project Grant
- NIH [5 K22 CA181412]
- Department of Health in Taiwan [MOHW103-TD-B-111-05, MOHW103-TDU-M-221-123017, DOH102-TD-M-111-102001]
Twist has been shown to cause treatment failure, cancer progression, and cancer-related death. However, strategies that directly target Twist are not yet conceivable. Here we reveal that K63-linked ubiquitination is a crucial regulatory mechanism for Twist activation. Through an E3 ligase screen and biochemical studies, we unexpectedly identified that RNF8 functions as a direct Twist activator by triggering K63-linked ubiquitination of Twist. RNF8-promoted Twist ubiquitination is required for Twist localization to the nucleus for subsequent EMT and CSC functions, thereby conferring chemoresistance. Our histological analyses showed that RNF8 expression is upregulated and correlated with disease progression, EMT features, and poor patient survival in breast cancer. Moreover, RNF8 regulates cancer cell migration and invasion and cancer metastasis, recapitulating the effect of Twist. Together, our findings reveal a previously unrecognized tumor-promoting function of RNF8 and provide evidence that targeting RNF8 is an appealing strategy to tackle tumor aggressiveness and treatment resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据